Nectar Lifescience Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹1.29 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.00 per cent from ₹0.00 crore. This corresponds to a year-on-year *(YoY) growth of 12,800.00 per cent.
Operating Profit
Operating Profit stands at ₹-87.95 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 4,480.73 per cent from ₹-1.92 crore. This corresponds to a year-on-year *(YoY) growth of 32.36 per cent.
PBDT
PBDT stands at ₹-87.56 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2,745.32 per cent from ₹3.31 crore. This corresponds to a year-on-year *(YoY) growth of 32.57 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-87.64 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2,796.62 per cent from ₹3.25 crore. This corresponds to a year-on-year *(YoY) growth of 32.66 per cent.
Net Profit
Net Profit stands at ₹-67.92 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 575.96 per cent from ₹14.27 crore. This represents a 47.79 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Nectar Lifescience Ltd Earnings
- YOY
- QOQ
Nectar Lifescience Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Nectar Lifescience Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Nectar Lifescience Ltd Financial Reports
Nectar Lifescience Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Nectar Lifesci. | -1.05% | 0.90% | 0.90% | 5.76% | -33.19% | -50.76% |
| Everest Organics | -3.09% | -3.79% | -1.20% | -12.37% | -37.11% | -40.07% |
| Astonea Labs | 3.23% | 3.93% | 48.66% | 50.16% | 58.67% | 75.45% |
| Kerala Ayurveda | -3.27% | -9.06% | -9.56% | -13.12% | -48.17% | -55.09% |
| Syschem (India) | 1.02% | -5.91% | -6.04% | -0.63% | -11.15% | 3.24% |
| Aarey Drugs | 2.28% | -1.26% | -12.87% | 11.73% | -6.44% | 51.37% |
| BDH Industries | 2.32% | 2.38% | -2.70% | -5.52% | -2.54% | 46.77% |
Company Info
Company Information
Chairman & Managing Director : Sanjiv Goyal
Independent Non Exe. Director : Rupinder Tewari
Independent Non Exe. Director : Kuldip Kumar Bhasin
Independent Non Exe. Director : Indu Pal Kaur
Executive Director : Surulichamy Senthilkumar
Company Sec. & Compli. Officer : Sanjaymohan Singh Rawat
WTD & Director (Finance) : Sushil Kapoor